2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hotspots in Plasmodium and RBC Receptor-Ligand Interactions: Key Pieces for Inhibiting Malarial Parasite Invasion

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Protein-protein interactions (IPP) play an essential role in practically all biological processes, including those related to microorganism invasion of their host cells. It has been found that a broad repertoire of receptor-ligand interactions takes place in the binding interphase with host cells in malaria, these being vital interactions for successful parasite invasion. Several trials have been conducted for elucidating the molecular interface of interactions between some Plasmodium falciparum and Plasmodium vivax antigens with receptors on erythrocytes and/or reticulocytes. Structural information concerning these complexes is available; however, deeper analysis is required for correlating structural, functional (binding, invasion, and inhibition), and polymorphism data for elucidating new interaction hotspots to which malaria control methods can be directed. This review describes and discusses recent structural and functional details regarding three relevant interactions during erythrocyte invasion: Duffy-binding protein 1 (DBP1)–Duffy antigen receptor for chemokines (DARC); reticulocyte-binding protein homolog 5 ( PfRh5)-basigin, and erythrocyte binding antigen 175 (EBA175)-glycophorin A (GPA).

          Related collections

          Most cited references98

          • Record: found
          • Abstract: found
          • Article: not found

          A proteomic view of the Plasmodium falciparum life cycle.

          The completion of the Plasmodium falciparum clone 3D7 genome provides a basis on which to conduct comparative proteomics studies of this human pathogen. Here, we applied a high-throughput proteomics approach to identify new potential drug and vaccine targets and to better understand the biology of this complex protozoan parasite. We characterized four stages of the parasite life cycle (sporozoites, merozoites, trophozoites and gametocytes) by multidimensional protein identification technology. Functional profiling of over 2,400 proteins agreed with the physiology of each stage. Unexpectedly, the antigenically variant proteins of var and rif genes, defined as molecules on the surface of infected erythrocytes, were also largely expressed in sporozoites. The detection of chromosomal clusters encoding co-expressed proteins suggested a potential mechanism for controlling gene expression.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing

            Malaria elimination strategies require surveillance of the parasite population for genetic changes that demand a public health response, such as new forms of drug resistance. 1,2 Here we describe methods for large-scale analysis of genetic variation in Plasmodium falciparum by deep sequencing of parasite DNA obtained from the blood of patients with malaria, either directly or after short term culture. Analysis of 86,158 exonic SNPs that passed genotyping quality control in 227 samples from Africa, Asia and Oceania provides genome-wide estimates of allele frequency distribution, population structure and linkage disequilibrium. By comparing the genetic diversity of individual infections with that of the local parasite population, we derive a metric of within-host diversity that is related to the level of inbreeding in the population. An open-access web application has been established for exploration of regional differences in allele frequency and of highly differentiated loci in the P. falciparum genome.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Malaria

              Malaria is caused in humans by five species of single-celled eukaryotic Plasmodium parasites (mainly Plasmodium falciparum and Plasmodium vivax) that are transmitted by the bite of Anopheles spp. mosquitoes. Malaria remains one of the most serious infectious diseases; it threatens nearly half of the world's population and led to hundreds of thousands of deaths in 2015, predominantly among children in Africa. Malaria is managed through a combination of vector control approaches (such as insecticide spraying and the use of insecticide-treated bed nets) and drugs for both treatment and prevention. The widespread use of artemisinin-based combination therapies has contributed to substantial declines in the number of malaria-related deaths; however, the emergence of drug resistance threatens to reverse this progress. Advances in our understanding of the underlying molecular basis of pathogenesis have fuelled the development of new diagnostics, drugs and insecticides. Several new combination therapies are in clinical development that have efficacy against drug-resistant parasites and the potential to be used in single-dose regimens to improve compliance. This ambitious programme to eliminate malaria also includes new approaches that could yield malaria vaccines or novel vector control strategies. However, despite these achievements, a well-coordinated global effort on multiple fronts is needed if malaria elimination is to be achieved.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                02 July 2020
                July 2020
                : 21
                : 13
                : 4729
                Affiliations
                [1 ]Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá 111321, Colombia; jesmolina@ 123456uniboyaca.edu.co (J.M.-F.); mepatarr@ 123456gmail.com (M.E.P.)
                [2 ]School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24#63C-69, Bogotá 112111, Colombia; gabriela.arevalo@ 123456urosario.edu.co
                [3 ]Ph.D. Programme in Biomedical and Biological Sciences, Universidad del Rosario, Carrera 24#63C-69, Bogotá 112111, Colombia; aligomez@ 123456uniboyaca.edu.co
                [4 ]Medicine Programme, Health Sciences Faculty, Universidad de Boyacá, Carrera 2ª Este#64-169, Tunja 150003, Colombia
                [5 ]Biology and Microbiology Department, Sciences and Engineering Faculty, Universidad de Boyacá, Carrera 2ª Este#64-169, Tunja 150003, Colombia
                [6 ]Receptor-Ligand Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá 111321, Colombia
                [7 ]Universidad Nacional de Colombia, Carrera 45 # 26-85, Bogotá 111321, Colombia
                Author notes
                Author information
                https://orcid.org/0000-0002-4751-2500
                https://orcid.org/0000-0001-6865-3153
                https://orcid.org/0000-0002-5331-5693
                Article
                ijms-21-04729
                10.3390/ijms21134729
                7370042
                32630804
                411c0b90-2645-4d8e-8f32-5e885b8c8eb3
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 04 April 2020
                : 24 May 2020
                Categories
                Review

                Molecular biology
                malaria,plasmodium,receptor-ligand structure,structure activity relationship
                Molecular biology
                malaria, plasmodium, receptor-ligand structure, structure activity relationship

                Comments

                Comment on this article